Locations:

Tag: transcatheter edge-to-edge repair (TEER)

severe tricuspid regurgitation on an echocardiogram

May 13, 2024/Heart, Vascular and Thoracic/Heart Valve Disease

What to Expect Now That Transcatheter Tricuspid Valve Therapies Have Been Approved

Limited data and experience will translate to a cautious rollout

April 5, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

TRILUMINATE Pivotal Trial: What Are Its Implications for Tricuspid Regurgitation Care?

TEER is found to be a safe and good option for severe TR in select patients

March 6, 2023/Heart, Vascular and Thoracic/Heart Valve Disease

Final COAPT Results Show TEER Benefits Through 5 Years in Secondary MR

Superiority continues even after significant crossovers from control group at 2 years

March 24, 2022/Heart, Vascular and Thoracic/Heart Valve Disease

PRIMARY Trial Aims to Guide Choice of Percutaneous Vs. Surgical Repair of Degenerative Mitral Regurgitation

Essentials of the NIH study and how it compares with REPAIR MR

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

BackPage 1 of 1Next